politics
Kennedy faces anti-vax anger over hantavirus treatment legal protections
Key takeaways
- Kennedy Jr. pushed back on criticism from some Make America Healthy Again activists after he extended liability protections for drugmakers working to develop treatments for the Andes hantavirus strain.
- The HHS late last week extended legal protections through July 18 to manufacturers and distributors of the experimental antiviral drug favipiravir as a potential treatment.
- Kennedy signed a Public Readiness and Emergency Preparedness (PREP) Act declaration, which provides protections for health product manufacturers during a pandemic or a similarly declared public health crisis.
Why this matters: political developments that affect policy direction and public trust.
Kennedy Jr. pushed back on criticism from some Make America Healthy Again activists after he extended liability protections for drugmakers working to develop treatments for the Andes hantavirus strain.
The HHS late last week extended legal protections through July 18 to manufacturers and distributors of the experimental antiviral drug favipiravir as a potential treatment.
Kennedy signed a Public Readiness and Emergency Preparedness (PREP) Act declaration, which provides protections for health product manufacturers during a pandemic or a similarly declared public health crisis.
Article preview — originally published by The Hill. Full story at the source.
Read full story on The Hill →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from The Hill alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop